The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection (Q38949380)

7 September 2017

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection (English)

1 reference

7 September 2017

5

Gallo RC

1 reference

7 September 2017

Cocchi F

1

1 reference

7 September 2017

DeVico AL

2

1 reference

7 September 2017

Garzino-Demo A

3

1 reference

7 September 2017

Cara A

4

1 reference

7 September 2017

Lusso P

6

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

7 September 2017

1 reference

7 September 2017

2

1 reference

7 September 2017

1244-1247

1 reference

7 September 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1196-1244

7 September 2017

0 references

cites work

Molecular cloning and functional expression of a new human CC-chemokine receptor gene

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

The role of mononuclear phagocytes in HTLV-III/LAV infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

The molecular biology of leukocyte chemoattractant receptors

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Diversity of G proteins in signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Activation of dual T cell signaling pathways by the chemokine RANTES

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120.

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1244

7 January 2021

Identifiers

DOI

10.1038/NM1196-1244

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference